Key result
In patients with transient ischemic attack, statin use was associated with a lower risk of incident diabetes mellitus compared with nonuse (HR 0.545; 95% CI 0.457-0.650).
Why the study?
Statin therapy reduces recurrent TIA risk but has been linked to incident diabetes; whether statin therapy remains associated with higher DM risk in patients with TIA was unknown.
Does statin use influence the risk of incident diabetes mellitus in patients with newly diagnosed transient ischemic attack?
Cohort (n=8,342)
Does statin use influence the risk of incident diabetes mellitus in patients with newly diagnosed transient ischemic attack?
Hazard Ratio: 0.545 (95% CI 0.457–0.65)
In patients with transient ischemic attack, statin use is associated with a dose-dependent reduction in the risk of incident diabetes mellitus, contrasting with the increased risk often observed in general populations.
May challenge established statin-DM risk increase in TIA; leaves open causality and generalizability from observational data.
Statin therapy can effectively reduce recurrent transient ischemic attack (TIA) risk. However, studies have reported that statin use is associated with incidence of diabetes mellitus (DM). Whether statin therapy remains associated with higher DM risk in patients with TIA remains unknown. This study investigated whether statin treatment influences incident DM risk in patients with TIA. We conducted a retrospective cohort study using the Longitudinal Health Insurance Database 2000. Participants who were newly diagnosed with TIA (ICD-9-CM code 435) from 1 January 1997 to 31 December 2011 were recruited. The Kaplan-Meier method and Cox proportional risk model of time-dependent covariance were used. We enrolled 8342 patients with newly diagnosed TIA from 1 January 1997 to 31 December 2011. Of these, 1255 patients were classified as statin users and 7087 as nonusers. During the 14-year follow-up, the incidence of newly diagnosed DM was 0.545-fold lower in the statins group compared with nonusers (95% confidence interval [CI] = 0.457-0.650). According to cumulative defined daily doses (cDDDs), the adjusted hazard ratios for DM were 0.689, 0.594, and 0.463 when patients were treated with statins at cDDDs = 28-89, 90-180, and >180, respectively. In patients with TIA, statin use is associated with a lower incident DM risk compared with the nonuse of statins.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a cohort in Transient Ischemic Attack (n=8,342). Statin therapy vs. Nonusers was evaluated on Incident diabetes mellitus (HR 0.545, 95% CI 0.457-0.650). In patients with transient ischemic attack, statin use was associated with a lower risk of incident diabetes mellitus compared with nonuse (HR 0.545; 95% CI 0.457-0.650).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: